Concordant upregulation of type II-TGF-β-receptor, the cyclin-dependent kinases inhibitor P27(Kip1) and cyclin E in human atherosclerotic tissue: Implications for lesion cellularity

Atherosclerosis

Volumn 144, Issue 1, 1999, Pages 7-14

  Ihling, Christian ^a   Technau, Katja ^a   Gross, Volkmar ^b   Schulte Mönting, Jürgen ^a   Zeiher, Andreas M ^c   Schaefer, Hans E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Atherosclerois; Cell proliferation; Cyclin E; P27; TGF ; TGF receptors

Indexed keywords

ALPHA ACTIN; CD3 ANTIGEN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; T LYMPHOCYTE; TISSUE REPAIR; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; CAROTID ARTERIES; CELL CYCLE PROTEINS; CELL DIVISION; CULTURE TECHNIQUES; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0033013365     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00032-5     Document Type: Article

References (24)

1. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1065-1079.
2. Elledge S. Cell cycle checkpoints: preventing an identity crisis. Science. 274:1997;1664-1672.
3. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
4. Polyak K., Lee M.H., Erdumet-Bromage H. et al. Cloning of p27 Kip 1, a cyclin dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-76.
5. Cordon-Cardo C. Mutations of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol. 147:1995;545-560.
6. Polyak K., Kato J., Solomon M.J. et al. p27 Kip1, a cyclin-Cdk inhibitor links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
7. Pagano M., Pepperkok R., Lukas J., Baldin V., Ansorge W.J.B., Draetta G. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol. 121:1993;101-111.
8. Gold L.I., Sung J.J., Siebert J.W., Longaker M.T. Type I (RI) and Type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair. Am J Pathol. 150:1997;209-222.
9. Moses H.L., Yang E.Y., Pietenpol J.A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 63:1990;245-247.
10. Koff A., Ohtsuki M., Polyak K., Roberts J.M., Massagué J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β Science. 260:1993;536-539.
11. Laiho M., Decaprio J.A., Ludlow J.W., Livingston D.M., Maasagué J. Growth inhibition by TGF-β linked to suppression of retinoblastom protein phosphorylation. Cell. 62:1990;175-185.
12. Attisano L., Wrana J. Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev. 7:1996;327-339.
13. Tanner F.C., Yang Z.J., Duckers E., Gordon D., Nabel G.J., Nabel E. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res. 82:1998;396-403.
14. Antonov A.S., Munn D.H., Kolodgie F.D., Virmani R., Gerrity R.G. Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27 (Kip1) regulatory checkpoint. J Clin Invest. 99:1997;2867-2876.
15. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592.
16. Ihling C., Menzel G., Wellens E., Schulte Mönting J., Schaefer H.E., Zeiher A.M. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscl Thromb Vasc Biol. 17:1997;2218-2224.
17. Pardee A.B. G1 events and the regulation of cell proliferation. Science. 246:1989;603-608.
18. Ihling C., Haendeler J., Menzel G. et al. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol. 185:1998;303-312.
19. Ophascharoensuk V., Fero M.L., Hughes J., Roberts J.M., Shankland S.J. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nature Med. 4:1998;575-580.
20. Sporn M.B., Todaro G.J. Autocrine secretion and malignant transformation of cells. New Engl J Med. 303:1980;878-880.
21. Liau G., Chan L.M. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J Biol Chem. 264:1989;10315-10320.
22. Battegay E.J., Raines E.W., Seifert R.A., Bowen P.D.F., Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63:1990;515-524.
23. O'Brien E.R., Alpers C.E., Stewart D.K. et al. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
24. Pickering J.G., Weir L., Jekanowsky J., Kearney M.A., Isner J.M. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 91:1993;1469-1480.